Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response

Margareth C. Ozelo, Barbara Vidal, Christine Brown, Colleen Notley, Carol Hegadorn, Sandra Webster, Lori Harpell, James Ahlin, Andrew Winterborn, Janine Handforth, Valder R. Arruda, Christine Hough, David Lillicrap

Blood (2014) 123 (26): 4045–4053.

https://doi.org/10.1182/blood-2013-12-545780

Published: 2014

Includes: Supplemental data

Journal Articles

A Modified Model of Type 2B von Willebrand Disease: Taking ADAMTS13-Mediated Cleavage out of the Equation

Mia Golder, Cynthia M. Pruss, PhD, Kate Sponagle, Carol Hegadorn, Erin Burnett, Andrea Bryant, David Lillicrap, MD

Blood (2010) 116 (21): 23.

https://doi.org/10.1182/blood.V116.21.23.23

Published: 2010

Journal Articles

Mouse Models of the Common, Recurring Type 1 von Willebrand Disease Mutations Y1584C and R1205H

Cynthia M. Pruss, PhD, Mia Golder, Andrea Bryant, Erin Burnett, Kate Sponagle, Carol Hegadorn, Sandra L. Haberichter, PhD, David Lillicrap, MD

Blood (2010) 116 (21): 22.

https://doi.org/10.1182/blood.V116.21.22.22

Published: 2010

Journal Articles

Association of Quantitative and Qualitative Abnormalities of Von Willebrand Factor and Risk of Death In Hemodialysis Patients

Rachel Holden, MD, Angie Tuttle, Francis MacLeod, Toni Burbidge, Carol Hegadorn, Paula D. James, MD

Blood (2010) 116 (21): 2217.

https://doi.org/10.1182/blood.V116.21.2217.2217

Published: 2010

Journal Articles

Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions

Mia Golder, Cynthia M. Pruss, Carol Hegadorn, Jeffrey Mewburn, Kimberly Laverty, Kate Sponagle, David Lillicrap

Blood (2010) 115 (23): 4862–4869.

https://doi.org/10.1182/blood-2009-11-253120

Published: 2010

Journal Articles

A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3 + T regulatory cells

Hideto Matsui, Masaru Shibata, Brian Brown, Andrea Labelle, Carol Hegadorn, Chandler Andrews, Marinee Chuah, Thierry VandenDriessche, Carol H. Miao, Christine Hough, David Lillicrap

Blood (2009) 114 (3): 677–685.

https://doi.org/10.1182/blood-2009-03-202267

Published: 2009

Journal Articles

Long-Term Phenotypic Correction of Hemophilia A Mice Following Intravenous Injection of miRNA-Regulated Lentiviral Vectors.

Hideto Matsui, MD, PhD, Margareth Ozelo, MD/PhD, Carol Hegadorn, Andrea Labelle, Erin Burnett, Angie Tuttle, Brian Brown, PhD, Luigi Naldini, MD/PhD, Christine Hough, PhD, David Lillicrap, MD

Blood (2007) 110 (11): 2587.

https://doi.org/10.1182/blood.V110.11.2587.2587

Published: 2007

Journal Articles

Ex Vivo Gene Trasfer for Hemophilia A That Enhances Safety and Results in Sustained In Vivo Factor VIII Expression from Lentivirally-Engineered Endothelial Progenitors.

Hideto Matsui, MD, PhD, Masaru Shibata, MD/PhD, Brian Brown, PhD, Andrea Labelle, Carol Hegadorn, Chandler Andrews, Robert P. Hebbel, MD, Jacques Galipeau, MD, Christine Hough, PhD, David Lillicrap, MD

Blood (2006) 108 (11): 3251.

https://doi.org/10.1182/blood.V108.11.3251.3251

Published: 2006

Journal Articles

The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study

Paula D. James, Colleen Notley, Carol Hegadorn, Jayne Leggo, Angie Tuttle, Shawn Tinlin, Christine Brown, Chandler Andrews, Andrea Labelle, Yvette Chirinian, Lee O'Brien, Maha Othman, Georges Rivard, Dilys Rapson, Christine Hough, David Lillicrap, for the Association of Hemophilia Clinic Directors of Canada

Blood (2006) 109 (1): 145–154.

https://doi.org/10.1182/blood-2006-05-021105

Published: 2006

Journal Articles

Cell type–specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor

Christine Hough, Carla D. Cuthbert, Colleen Notley, Christine Brown, Carol Hegadorn, Ergul Berber, David Lillicrap

Blood (2005) 105 (4): 1531–1539.

https://doi.org/10.1182/blood-2002-10-3093

Published: 2005

NARROW

Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response

A Modified Model of Type 2B von Willebrand Disease: Taking ADAMTS13-Mediated Cleavage out of the Equation

Mouse Models of the Common, Recurring Type 1 von Willebrand Disease Mutations Y1584C and R1205H

Association of Quantitative and Qualitative Abnormalities of Von Willebrand Factor and Risk of Death In Hemodialysis Patients

Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions

A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3 + T regulatory cells

Long-Term Phenotypic Correction of Hemophilia A Mice Following Intravenous Injection of miRNA-Regulated Lentiviral Vectors.

Ex Vivo Gene Trasfer for Hemophilia A That Enhances Safety and Results in Sustained In Vivo Factor VIII Expression from Lentivirally-Engineered Endothelial Progenitors.

The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study

Cell type–specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only